Myasthenia gravis: nicotinic acetylcholine receptors as targets for autoimmune attack.
Newsom-Davis
J
J
Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, U.K.
Harcourt
G
G
Beeson
D
D
D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D009157:Myasthenia Gravis / Q000276:immunology*; D011817:Rabbits; D011978:Receptors, Nicotinic / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology
D001323:Autoantibodies; D011978:Receptors, Nicotinic